NCT02513303: A trial that was reported late by Vascular Therapies, Inc.
This trial has reported, although it was 449 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02513303 |
|---|---|
| Title | A Phase 3, Randomized, Multicenter, Single-blind, Controlled Study Evaluating Arteriovenous Fistula Outcomes With and Without a Perivascular Sirolimus-Eluting Collagen Implant |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Nov. 30, 2015 |
| Completion date | June 30, 2021 |
| Required reporting date | June 30, 2024, midnight |
| Actual reporting date | Sept. 22, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 449 |